
A Cardiology Pharmacy Podcast reviewing recent cardiology literature with hosts @SchwietTMac & @val_smartan; podcast editing @tweetlessnathan
Joined September 2019
- Tweets166
- Following35
- Followers959
- Likes141
Happy Fall! Fall into a great discussion of the CLEAR Outcomes trial as @JurgaTomek discusses the current landscape of cholesterol management! @accpcardprn
apple.co/346sc9q
Fall is [basically] here. The TIME of the year for pumpkins (including lattes), football, and a brand new CardioScripts episode. Check out the latest episode with guest @Ricky_Turgeon and his great discussion of the TIME trial! ⏰💊🏈🍁
@accpcardprn
podcasts.apple.com/us/podcas…
Summer is almost here! Relax poolside with CardioScript's newest episode featuring @DrHeartbeats discussing the STRONG-HF trial! @accpcardprn @bcmhouston @VAHouston @UH_Pharmacy
Link: podcasts.apple.com/us/podcas…
Take a break from debating if it's too early to listen to Christmas music (is it?) and check out the newest CardioScripts episode with @JurgaTomek and his thoughts on the DELIVER trial. It's a pretty sweet episode! @accpcardprn
apple.co/346sc9q
Welcome Back for Season 3 of CardioScripts! Let’s kick it off with the recent ADVOR trial with guest @Zac0x!
apple.co/346sc9q
Does this Tuesday feel like a Monday? Make it feel more like Friday with the latest CardioScripts episode reviewing the TTM2 trial with Dr. Kevin Donahue! *note - regardless of the Friday feels, tomorrow is still Wednesday* @accpcardprn
podcasts.apple.com/us/podcas…
Need motivation to stick to your New Year’s Resolutions? Check out the latest CardioScripts episode where Mary Blanton Covell reviews the cardiovascular benefits of exercise! @accpcardprn
apple.co/346sc9q
Still trying to master DAPT therapy duration? Don’t worry we are too! But we’re thankful to have @ASchenkPharmD this episode to discuss the MASTER-DAPT trial and we’re thankful for all our listeners! Happy Thanksgiving! @accpcardprn
apple.co/346sc9q
👑 Check out our latest episode with @agoncha259 discussing the EMPEROR-Preserved trial👑 Is the reign of SGLT2 inhibitors here to stay? @accpcardprn
apple.co/346sc9q
Treating cardiogenic shock with milrinone and dobutamine - these are a few of our favorite things! Listen as @michael_plazak discusses the DOREMI trial.@accpcardprn
apple.co/346sc9q